Skip to main content

Amber Cipriani

Clinical Assistant Professor

Amber Cipriani, Pharm.D., BCOP

Clinical Assistant Professor

984-974-0767, Office Phone
2318 Kerr Hall, 301 Pharmacy Lane, , Chapel Hill, NC, 27599

Amber Cipriani joined the UNC Eshelman School of Pharmacy as a clinical assistant professor in the Division of Pharmacotherapy and Experimental Therapy in August of 2015. Cipriani’s appointment is co-funded by UNC Hospitals, where she serves as the Precision Medicine Pharmacy Coordinator.

Dr. Cipriani worked to establish a pharmacy presence in the ambulatory oncology clinics for lung, sarcoma, head and neck and melanoma malignancies at UNC Hospitals before transitioning to her role in Precision Medicine. In her current clinical role, she works to implement initiatives that improve medication use and management through the utilization of technology, genetics, and clinical decision support tools. Dr. Cipriani focuses on implementation in the areas of pharmacogenomics and precision oncology. She is a member of UNC’s Oncology Molecular Tumor Board and works closely with the Program for Precision Medicine in Health Care. At the School, Dr. Cipriani coordinates two electives offered to third year pharmacy students (PHC 837:Pharmacogenomics and PHCY 822: Hematology/Oncology Pharmacotherapy) along with her participation as a faculty member in PHCY 502, PHCY 510, and PHCY 733.

Dr. Cipriani received a BA in Biochemistry and in Molecular,Cellular, and Developmental Biology from the University of Colorado in Boulder. She developed her laboratory skills as a research assistant for a drug development company before completing her PharmD degree at the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences in Denver. She then pursued PGY1 Pharmacy Practice and PGY2 Hematology/Oncology training at the University of North Carolina. She is board certified in Oncology.

Dr. Cipriani’s research interests include exploring real-world use of oncology medications to identify the most appropriate dose and patient characteristics that ensure safe and efficacious use. She is interested in utilizing genomic and transcriptomic information to guide clinical use of drugs, especially in the area of oncology. She is interested in researching implementation strategies for precision medicine in healthcare systems. For publications, see

  • Pharm.D., University of Colorado – Skaggs School of Pharmacy and Pharmaceutical Sciences
  • B.A. in Biochemistry & B.A. in Molecular, Cellular, and Developmental Biology – University of Colorado